Skip to main content
logo
Alivus Life Sciences Limited (NSE:ALIVUS)
India flag India · Delayed Price · Currency is INR
1,350.90
-19.10 (-1.39%)
Aug 21, 2026, 3:29 PM IST

Alivus Life Sciences Revenue

Alivus Life Sciences had revenue of 6.40B INR in the quarter ending June 30, 2026, with 6.41% growth. This brings the company's revenue in the last twelve months to 25.90B, up 7.93% year-over-year. In the fiscal year ending March 31, 2026, Alivus Life Sciences had annual revenue of 25.52B with 6.91% growth.

Revenue (ttm)
25.90B
Revenue Growth
+7.93%
P/S Ratio
6.40
Revenue / Employee
11.40M
Employees
2,272
Market Cap
165.81B

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202625.52B1.65B6.91%
Mar 31, 202523.87B1.04B4.54%
Mar 31, 202422.83B1.22B5.64%
Mar 31, 202321.61B380.06M1.79%
Mar 31, 202221.23B2.38B12.63%
Mar 31, 2021 Pro Pro Pro
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Emcure Pharmaceuticals96.83B
Piramal Pharma92.05B
Alembic Pharmaceuticals77.84B
Strides Pharma Science50.04B
Akums Drugs and Pharmaceuticals45.04B
Wockhardt36.53B
NATCO Pharma34.85B
Eris Lifesciences32.12B
Revenue Rankings

Alivus Life Sciences News

More News